Importantly, CLDN1 is pinpointed as a direct transcriptional target of Hh pathway activation in breast cancer, as evidenced by the correlation between membranous CLDN1 expression and Hh paracrine pathway activation [109]. The gene discussed is CLDN1; the disease is breast carcinoma.